{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:23:30Z","timestamp":1773303810480,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.nbd.2011.03.021","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T22:29:52Z","timestamp":1303165792000},"page":"322-329","source":"Crossref","is-referenced-by-count":121,"title":["A pulse rapamycin therapy for infantile spasms and associated cognitive decline"],"prefix":"10.1016","volume":"43","author":[{"given":"Emmanuel","family":"Raffo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonietta","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen W.","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristea S.","family":"Galanopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nbd.2011.03.021_bb0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.97.3.375","article-title":"High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study","volume":"97","author":"Baram","year":"1996","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.nbd.2011.03.021_bb0015","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.nbd.2011.03.021_bb0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1528-1167.2010.02777.x","article-title":"The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission","volume":"52","author":"Blumcke","year":"2011","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00007691-199708000-00007","article-title":"Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients","volume":"19","author":"Brattstrom","year":"1997","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.nbd.2011.03.021_bb0030","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1523\/JNEUROSCI.4852-10.2011","article-title":"Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy","volume":"31","author":"Buckmaster","year":"2011","journal-title":"J. Neurosci."},{"issue":"25","key":"10.1016\/j.nbd.2011.03.021_bb0035","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1523\/JNEUROSCI.4179-08.2009","article-title":"Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy","volume":"29","author":"Buckmaster","year":"2009","journal-title":"J. Neurosci."},{"issue":"Suppl 3","key":"10.1016\/j.nbd.2011.03.021_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1528-1167.2010.02633.x","article-title":"Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II","volume":"51","author":"Cepeda","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2011.03.021_bb0045","first-page":"S52","article-title":"Therapeutic trial of vigabatrin in refractory infantile spasms","volume":"Suppl 2","author":"Chiron","year":"1991","journal-title":"J. Child Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.nbd.2011.03.021_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2010.02605.x","article-title":"Modeling new therapies for infantile spasms","volume":"51","author":"Chudomelova","year":"2010","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.nbd.2011.03.021_bb0055","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2011.03.021_bb0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/9780470994030.ch18","article-title":"Focal brain malformations: a spectrum of disorders along the mTOR cascade","volume":"288","author":"Crino","year":"2007","journal-title":"Novartis Found. Symp."},{"issue":"Suppl 1","key":"10.1016\/j.nbd.2011.03.021_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02438.x","article-title":"The pathophysiology of tuberous sclerosis complex","volume":"51","author":"Crino","year":"2010","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.nbd.2011.03.021_bb0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0090-9556(24)15260-9","article-title":"Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats","volume":"27","author":"Crowe","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.nbd.2011.03.021_bb0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0387-7604(01)00300-X","article-title":"Infantile spasms in tuberous sclerosis complex","volume":"23","author":"Curatolo","year":"2001","journal-title":"Brain Dev."},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0080","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1528-1167.2006.00976.x","article-title":"Rapamycin: brain excitability studied in vitro","volume":"48","author":"Daoud","year":"2007","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.nbd.2011.03.021_bb0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/adc.2009.160606","article-title":"Developmental and epilepsy outcomes at age 4years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial","volume":"95","author":"Darke","year":"2010","journal-title":"Arch. Dis. Child."},{"issue":"8","key":"10.1016\/j.nbd.2011.03.021_bb0090","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.nbd.2011.03.021_bb0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2788.2009.01208.x","article-title":"From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis","volume":"53","author":"Ehninger","year":"2009","journal-title":"J. Intellect. Disabil. Res."},{"issue":"9","key":"10.1016\/j.nbd.2011.03.021_bb0100","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1528-1167.2006.00215.x","article-title":"Report of the ILAE classification core group","volume":"47","author":"Engel","year":"2006","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.nbd.2011.03.021_bb0105","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.braindev.2006.03.011","article-title":"Ketogenic diet for treatment of infantile spasms","volume":"28","author":"Eun","year":"2006","journal-title":"Brain Dev."},{"issue":"7","key":"10.1016\/j.nbd.2011.03.021_bb0110","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1523\/JNEUROSCI.5180-07.2008","article-title":"Dissociated gender-specific effects of recurrent seizures on GABA signaling in CA1 pyramidal neurons: role of GABA(A) receptors","volume":"28","author":"Galanopoulou","year":"2008","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2011.03.021_bb0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00004691-200311000-00004","article-title":"Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms\/West syndrome)","volume":"20","author":"Hrachovy","year":"2003","journal-title":"J. Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.nbd.2011.03.021_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nbd.2010.05.024","article-title":"Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy","volume":"40","author":"Huang","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.nbd.2011.03.021_bb0125","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/j.1528-1167.2010.02547.x","article-title":"Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias","volume":"51","author":"Iyer","year":"2010","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.nbd.2011.03.021_bb0130","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1528-1167.2008.01606.x","article-title":"A case-control evaluation of the ketogenic diet versus ACTH for new-onset infantile spasms","volume":"49","author":"Kossoff","year":"2008","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0135","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.yebeh.2009.01.023","article-title":"High-dose oral prednisolone for infantile spasms: an effective and less expensive alternative to ACTH","volume":"14","author":"Kossoff","year":"2009","journal-title":"Epilepsy Behav."},{"issue":"5994","key":"10.1016\/j.nbd.2011.03.021_bb0140","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"issue":"7\u20138","key":"10.1016\/j.nbd.2011.03.021_bb0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/dmm.002386","article-title":"Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia","volume":"2","author":"Ljungberg","year":"2009","journal-title":"Dis. Model. Mech."},{"issue":"2","key":"10.1016\/j.nbd.2011.03.021_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1528-1157.1983.tb04874.x","article-title":"A prospective study of infantile spasms: clinical and therapeutic correlations","volume":"24","author":"Lombroso","year":"1983","journal-title":"Epilepsia"},{"issue":"9447","key":"10.1016\/j.nbd.2011.03.021_bb0155","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14days: a multicentre, randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.nbd.2011.03.021_bb0160","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(05)70199-X","article-title":"The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14months: a multicentre randomised trial","volume":"4","author":"Lux","year":"2005","journal-title":"Lancet Neurol."},{"issue":"Suppl B","key":"10.1016\/j.nbd.2011.03.021_bb0165","doi-asserted-by":"crossref","first-page":"B101","DOI":"10.1016\/S0149-2918(00)89027-X","article-title":"Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","volume":"22","author":"MacDonald","year":"2000","journal-title":"Clin. Ther."},{"issue":"10","key":"10.1016\/j.nbd.2011.03.021_bb0170","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/01.WNL.0000127773.72699.C8","article-title":"Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society","volume":"62","author":"Mackay","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2011.03.021_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1877-1173(09)90003-5","article-title":"Chapter 3 ribosomal protein S6 kinase from TOP mRNAs to cell size","volume":"90","author":"Meyuhas","year":"2009","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073808324535","article-title":"Rapamycin reduces seizure frequency in tuberous sclerosis complex","volume":"24","author":"Muncy","year":"2009","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.nbd.2011.03.021_bb0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","article-title":"The tuberous sclerosis complex","volume":"1184","author":"Orlova","year":"2010","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.nbd.2011.03.021_bb0195","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1528-1167.2010.02657.x","article-title":"Infantile spasms: A U.S. consensus report","volume":"51","author":"Pellock","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.nbd.2011.03.021_bb0200","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2007.08.012","article-title":"Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy","volume":"29","author":"Ravizza","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.nbd.2011.03.021_bb0205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2008-1059590","article-title":"A long-term follow-up study of 214 children with the syndrome of infantile spasms","volume":"13","author":"Riikonen","year":"1982","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.nbd.2011.03.021_bb0210","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0387-7604(01)00307-2","article-title":"Long-term outcome of patients with West syndrome","volume":"23","author":"Riikonen","year":"2001","journal-title":"Brain Dev."},{"issue":"1","key":"10.1016\/j.nbd.2011.03.021_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejpn.2009.03.004","article-title":"Favourable prognostic factors with infantile spasms","volume":"14","author":"Riikonen","year":"2010","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"2\u20133","key":"10.1016\/j.nbd.2011.03.021_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2007.09.009","article-title":"Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons","volume":"77","author":"Ruegg","year":"2007","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.nbd.2011.03.021_bb0225","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.nbd.2009.11.011","article-title":"A model of symptomatic infantile spasms syndrome","volume":"37","author":"Scantlebury","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2011.03.021_bb0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1399-3046.2003.00148.x","article-title":"Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol","volume":"8","author":"Schachter","year":"2004","journal-title":"Pediatr. Transplant."},{"issue":"7327","key":"10.1016\/j.nbd.2011.03.021_bb0235","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nature09584","article-title":"mTORC1 controls fasting-induced ketogenesis and its modulation by ageing","volume":"468","author":"Sengupta","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.nbd.2011.03.021_bb0240","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","article-title":"Dysregulation of mTOR signaling in fragile X syndrome","volume":"30","author":"Sharma","year":"2010","journal-title":"J. Neurosci."},{"issue":"23","key":"10.1016\/j.nbd.2011.03.021_bb0245","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4161\/cc.8.23.10070","article-title":"Targeting mTOR globally in cancer: thinking beyond rapamycin","volume":"8","author":"Shor","year":"2009","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.nbd.2011.03.021_bb0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1535-7511.2009.01299.x","article-title":"Infantile spasms: a critical review of emerging animal models","volume":"9","author":"Stafstrom","year":"2009","journal-title":"Epilepsy Curr."},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0255","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.21342","article-title":"Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers","volume":"63","author":"Talos","year":"2008","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2011.03.021_bb0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1535-7511.2008.00243.x","article-title":"Innate immunity and inflammation in temporal lobe epilepsy: new emphasis on the role of complement activation","volume":"8","author":"Vezzani","year":"2008","journal-title":"Epilepsy Curr"},{"issue":"12","key":"10.1016\/j.nbd.2011.03.021_bb0265","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","article-title":"Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study","volume":"38","author":"Vigevano","year":"1997","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2011.03.021_bb0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2006.03.011","article-title":"A role for the mTOR pathway in surface expression of AMPA receptors","volume":"401","author":"Wang","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR signaling pathway regulates the innate inflammatory response","volume":"29","author":"Weichhart","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.nbd.2011.03.021_bb0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1528-1167.2008.01988.x","article-title":"Vigabatrin: 2008 update","volume":"50","author":"Willmore","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.nbd.2011.03.021_bb0285","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.nbd.2011.03.021_bb0290","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbrc.2010.02.038","article-title":"PI3K\/Akt\/mTOR signaling regulates glutamate transporter 1 in astrocytes","volume":"393","author":"Wu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.nbd.2011.03.021_bb0295","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"issue":"21","key":"10.1016\/j.nbd.2011.03.021_bb0300","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","article-title":"The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy","volume":"29","author":"Zeng","year":"2009","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2011.03.021_bb0305","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5685-08.2009","article-title":"Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice","volume":"29","author":"Zhou","year":"2009","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111001161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111001161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T04:09:15Z","timestamp":1741147755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0969996111001161"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.03.021","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}